{"id":4203,"date":"2012-04-25T19:31:29","date_gmt":"2012-04-25T23:31:29","guid":{"rendered":"http:\/\/goldstocksforex.com\/?p=4203"},"modified":"2012-04-25T19:31:29","modified_gmt":"2012-04-25T23:31:29","slug":"an-earnings-season-only-a-pessimist-could-love-the-globe-and-mail","status":"publish","type":"post","link":"https:\/\/thepatientinvestor.com\/index.php\/2012\/04\/25\/an-earnings-season-only-a-pessimist-could-love-the-globe-and-mail\/","title":{"rendered":"An earnings season only a pessimist could love – The Globe and Mail"},"content":{"rendered":"

With more than 25 per cent of S&P 500 companies having reported their first-quarter results, 80 per cent have exceeded analysts\u2019 consensus profit estimates \u2013 a record pace, and well above the historical average of 62 per cent.<\/p>\n

….The record \u201cbeat rate,\u201d as earnings trackers call it, can\u2019t gloss over the fact that earnings forecasts have been in decline for months \u2013 leaving expectations so low that topping them is a dubious achievement……..Major earnings-tracking services such as Factset, Thomson Reuters Research and S&P Capital IQ expect S&P 500 year-over-year earnings growth of between 4 and 4.5 per cent for the quarter ended March 31. That would be the weakest profit growth in more than two years.<\/p>\n

via An earnings season only a pessimist could love – The Globe and Mail<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"

With more than 25 per cent of S&P 500 companies having reported their first-quarter results, 80 per cent have exceeded analysts\u2019 consensus profit estimates \u2013 a record pace, and well above the historical average of 62 per cent. ….The record \u201cbeat rate,\u201d as earnings trackers call it, can\u2019t gloss over the fact that earnings forecasts … <\/p>\n

Continue reading “An earnings season only a pessimist could love – The Globe and Mail”<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_mo_disable_npp":"","_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[57,34],"tags":[],"class_list":["post-4203","post","type-post","status-publish","format-standard","hentry","category-stock-markets","category-us-canada-countries-regions"],"yoast_head":"\nAn earnings season only a pessimist could love - The Globe and Mail - the patient investor<\/title>\n<meta name=\"robots\" content=\"noindex, follow\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"An earnings season only a pessimist could love - The Globe and Mail - the patient investor\" \/>\n<meta property=\"og:description\" content=\"With more than 25 per cent of S&P 500 companies having reported their first-quarter results, 80 per cent have exceeded analysts\u2019 consensus profit estimates \u2013 a record pace, and well above the historical average of 62 per cent. ….The record \u201cbeat rate,\u201d as earnings trackers call it, can\u2019t gloss over the fact that earnings forecasts … Continue reading "An earnings season only a pessimist could love – The Globe and Mail"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/thepatientinvestor.com\/index.php\/2012\/04\/25\/an-earnings-season-only-a-pessimist-could-love-the-globe-and-mail\/\" \/>\n<meta property=\"og:site_name\" content=\"the patient investor\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61572934660810\" \/>\n<meta property=\"article:author\" content=\"https:\/\/facebook.com\/people\/The-Patient-Investor\/61572934660810\/\" \/>\n<meta property=\"article:published_time\" content=\"2012-04-25T23:31:29+00:00\" \/>\n<meta name=\"author\" content=\"Colin Twiggs\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Colin Twiggs\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/index.php\\\/2012\\\/04\\\/25\\\/an-earnings-season-only-a-pessimist-could-love-the-globe-and-mail\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/index.php\\\/2012\\\/04\\\/25\\\/an-earnings-season-only-a-pessimist-could-love-the-globe-and-mail\\\/\"},\"author\":{\"name\":\"Colin Twiggs\",\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/#\\\/schema\\\/person\\\/d42b18d516a80149d739845749ac6454\"},\"headline\":\"An earnings season only a pessimist could love – The Globe and Mail\",\"datePublished\":\"2012-04-25T23:31:29+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/index.php\\\/2012\\\/04\\\/25\\\/an-earnings-season-only-a-pessimist-could-love-the-globe-and-mail\\\/\"},\"wordCount\":141,\"commentCount\":2,\"publisher\":{\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/#organization\"},\"articleSection\":[\"Stock Markets\",\"US & Canada\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/thepatientinvestor.com\\\/index.php\\\/2012\\\/04\\\/25\\\/an-earnings-season-only-a-pessimist-could-love-the-globe-and-mail\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/index.php\\\/2012\\\/04\\\/25\\\/an-earnings-season-only-a-pessimist-could-love-the-globe-and-mail\\\/\",\"url\":\"https:\\\/\\\/thepatientinvestor.com\\\/index.php\\\/2012\\\/04\\\/25\\\/an-earnings-season-only-a-pessimist-could-love-the-globe-and-mail\\\/\",\"name\":\"An earnings season only a pessimist could love - The Globe and Mail - the patient investor\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/#website\"},\"datePublished\":\"2012-04-25T23:31:29+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/index.php\\\/2012\\\/04\\\/25\\\/an-earnings-season-only-a-pessimist-could-love-the-globe-and-mail\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/thepatientinvestor.com\\\/index.php\\\/2012\\\/04\\\/25\\\/an-earnings-season-only-a-pessimist-could-love-the-globe-and-mail\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/index.php\\\/2012\\\/04\\\/25\\\/an-earnings-season-only-a-pessimist-could-love-the-globe-and-mail\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/thepatientinvestor.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"An earnings season only a pessimist could love – The Globe and Mail\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/#website\",\"url\":\"https:\\\/\\\/thepatientinvestor.com\\\/\",\"name\":\"The Patient Investor\",\"description\":\"Smart. Strategic. Unfiltered. \",\"publisher\":{\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/thepatientinvestor.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/#organization\",\"name\":\"The Patient Investor Pty Ltd\",\"url\":\"https:\\\/\\\/thepatientinvestor.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/i0.wp.com\\\/thepatientinvestor.com\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/cropped-cropped-patience-bg-1-inverted-400x400-1.png?fit=250%2C250&ssl=1\",\"contentUrl\":\"https:\\\/\\\/i0.wp.com\\\/thepatientinvestor.com\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/cropped-cropped-patience-bg-1-inverted-400x400-1.png?fit=250%2C250&ssl=1\",\"width\":250,\"height\":250,\"caption\":\"The Patient Investor Pty Ltd\"},\"image\":{\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61572934660810\",\"https:\\\/\\\/www.instagram.com\\\/colin_thepatientinvestor\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/#\\\/schema\\\/person\\\/d42b18d516a80149d739845749ac6454\",\"name\":\"Colin Twiggs\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/29a4e13250381b203ea835108c2d5eee4947439713c271ae5ba60afb53194432?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/29a4e13250381b203ea835108c2d5eee4947439713c271ae5ba60afb53194432?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/29a4e13250381b203ea835108c2d5eee4947439713c271ae5ba60afb53194432?s=96&d=mm&r=g\",\"caption\":\"Colin Twiggs\"},\"description\":\"Colin Twiggs is a former investment banker with almost 40 years of experience in financial markets. He co-founded Incredible Charts and writes the popular Trading Diary and Patient Investor newsletters. Using a top-down approach, Colin identifies key macro trends in the global economy before evaluating selected opportunities using a combination of fundamental and technical analysis. Focusing on interest rates and financial market liquidity as primary drivers of the economic cycle, he warned of the 2008\\\/2009 and 2020 bear markets well ahead of actual events. He founded PVT Capital (AFSL No. 546090) in May 2023, which offers investment strategy and advice to wholesale clients.\",\"sameAs\":[\"https:\\\/\\\/facebook.com\\\/people\\\/The-Patient-Investor\\\/61572934660810\\\/\",\"https:\\\/\\\/www.instagram.com\\\/colin_thepatientinvestor\",\"https:\\\/\\\/au.linkedin.com\\\/in\\\/colintwiggs\"],\"url\":\"https:\\\/\\\/thepatientinvestor.com\\\/index.php\\\/author\\\/investor\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"An earnings season only a pessimist could love - The Globe and Mail - the patient investor","robots":{"index":"noindex","follow":"follow"},"og_locale":"en_US","og_type":"article","og_title":"An earnings season only a pessimist could love - The Globe and Mail - the patient investor","og_description":"With more than 25 per cent of S&P 500 companies having reported their first-quarter results, 80 per cent have exceeded analysts\u2019 consensus profit estimates \u2013 a record pace, and well above the historical average of 62 per cent. ….The record \u201cbeat rate,\u201d as earnings trackers call it, can\u2019t gloss over the fact that earnings forecasts … Continue reading \"An earnings season only a pessimist could love – The Globe and Mail\"","og_url":"https:\/\/thepatientinvestor.com\/index.php\/2012\/04\/25\/an-earnings-season-only-a-pessimist-could-love-the-globe-and-mail\/","og_site_name":"the patient investor","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61572934660810","article_author":"https:\/\/facebook.com\/people\/The-Patient-Investor\/61572934660810\/","article_published_time":"2012-04-25T23:31:29+00:00","author":"Colin Twiggs","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Colin Twiggs","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/thepatientinvestor.com\/index.php\/2012\/04\/25\/an-earnings-season-only-a-pessimist-could-love-the-globe-and-mail\/#article","isPartOf":{"@id":"https:\/\/thepatientinvestor.com\/index.php\/2012\/04\/25\/an-earnings-season-only-a-pessimist-could-love-the-globe-and-mail\/"},"author":{"name":"Colin Twiggs","@id":"https:\/\/thepatientinvestor.com\/#\/schema\/person\/d42b18d516a80149d739845749ac6454"},"headline":"An earnings season only a pessimist could love – The Globe and Mail","datePublished":"2012-04-25T23:31:29+00:00","mainEntityOfPage":{"@id":"https:\/\/thepatientinvestor.com\/index.php\/2012\/04\/25\/an-earnings-season-only-a-pessimist-could-love-the-globe-and-mail\/"},"wordCount":141,"commentCount":2,"publisher":{"@id":"https:\/\/thepatientinvestor.com\/#organization"},"articleSection":["Stock Markets","US & Canada"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/thepatientinvestor.com\/index.php\/2012\/04\/25\/an-earnings-season-only-a-pessimist-could-love-the-globe-and-mail\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/thepatientinvestor.com\/index.php\/2012\/04\/25\/an-earnings-season-only-a-pessimist-could-love-the-globe-and-mail\/","url":"https:\/\/thepatientinvestor.com\/index.php\/2012\/04\/25\/an-earnings-season-only-a-pessimist-could-love-the-globe-and-mail\/","name":"An earnings season only a pessimist could love - The Globe and Mail - the patient investor","isPartOf":{"@id":"https:\/\/thepatientinvestor.com\/#website"},"datePublished":"2012-04-25T23:31:29+00:00","breadcrumb":{"@id":"https:\/\/thepatientinvestor.com\/index.php\/2012\/04\/25\/an-earnings-season-only-a-pessimist-could-love-the-globe-and-mail\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/thepatientinvestor.com\/index.php\/2012\/04\/25\/an-earnings-season-only-a-pessimist-could-love-the-globe-and-mail\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/thepatientinvestor.com\/index.php\/2012\/04\/25\/an-earnings-season-only-a-pessimist-could-love-the-globe-and-mail\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/thepatientinvestor.com\/"},{"@type":"ListItem","position":2,"name":"An earnings season only a pessimist could love – The Globe and Mail"}]},{"@type":"WebSite","@id":"https:\/\/thepatientinvestor.com\/#website","url":"https:\/\/thepatientinvestor.com\/","name":"The Patient Investor","description":"Smart. Strategic. Unfiltered. ","publisher":{"@id":"https:\/\/thepatientinvestor.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/thepatientinvestor.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/thepatientinvestor.com\/#organization","name":"The Patient Investor Pty Ltd","url":"https:\/\/thepatientinvestor.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/thepatientinvestor.com\/#\/schema\/logo\/image\/","url":"https:\/\/i0.wp.com\/thepatientinvestor.com\/wp-content\/uploads\/2026\/03\/cropped-cropped-patience-bg-1-inverted-400x400-1.png?fit=250%2C250&ssl=1","contentUrl":"https:\/\/i0.wp.com\/thepatientinvestor.com\/wp-content\/uploads\/2026\/03\/cropped-cropped-patience-bg-1-inverted-400x400-1.png?fit=250%2C250&ssl=1","width":250,"height":250,"caption":"The Patient Investor Pty Ltd"},"image":{"@id":"https:\/\/thepatientinvestor.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61572934660810","https:\/\/www.instagram.com\/colin_thepatientinvestor"]},{"@type":"Person","@id":"https:\/\/thepatientinvestor.com\/#\/schema\/person\/d42b18d516a80149d739845749ac6454","name":"Colin Twiggs","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/29a4e13250381b203ea835108c2d5eee4947439713c271ae5ba60afb53194432?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/29a4e13250381b203ea835108c2d5eee4947439713c271ae5ba60afb53194432?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/29a4e13250381b203ea835108c2d5eee4947439713c271ae5ba60afb53194432?s=96&d=mm&r=g","caption":"Colin Twiggs"},"description":"Colin Twiggs is a former investment banker with almost 40 years of experience in financial markets. He co-founded Incredible Charts and writes the popular Trading Diary and Patient Investor newsletters. Using a top-down approach, Colin identifies key macro trends in the global economy before evaluating selected opportunities using a combination of fundamental and technical analysis. Focusing on interest rates and financial market liquidity as primary drivers of the economic cycle, he warned of the 2008\/2009 and 2020 bear markets well ahead of actual events. He founded PVT Capital (AFSL No. 546090) in May 2023, which offers investment strategy and advice to wholesale clients.","sameAs":["https:\/\/facebook.com\/people\/The-Patient-Investor\/61572934660810\/","https:\/\/www.instagram.com\/colin_thepatientinvestor","https:\/\/au.linkedin.com\/in\/colintwiggs"],"url":"https:\/\/thepatientinvestor.com\/index.php\/author\/investor\/"}]}},"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/p9tQ4n-15N","jetpack_likes_enabled":false,"jetpack-related-posts":[{"id":18555,"url":"https:\/\/thepatientinvestor.com\/index.php\/2019\/07\/20\/buybacks-are-hurting-growth\/","url_meta":{"origin":4203,"position":0},"title":"Buybacks are hurting growth","author":"Colin Twiggs","date":"July 20, 2019","format":false,"excerpt":"Preliminary Q1 results from S&P Dow Jones Indices show S&P 500 dividends and buybacks continue to exceed reported earnings in the first quarter of the current year. While this could be a spill-over of offshore funds repatriated as a result of the 2017 Tax Cuts and Jobs Act, companies have\u2026","rel":"","context":"In "Stock Markets"","block_context":{"text":"Stock Markets","link":"https:\/\/thepatientinvestor.com\/index.php\/category\/stock-markets\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":52881,"url":"https:\/\/thepatientinvestor.com\/index.php\/2024\/05\/15\/sp-500-fundamentals-dont-stack-up\/","url_meta":{"origin":4203,"position":1},"title":"S&P 500 fundamentals don’t stack up","author":"Colin Twiggs","date":"May 15, 2024","format":false,"excerpt":"The S&P 500 threatens another advance, fueled by easy monetary conditions, but the fundamentals don't stack up. Sales and earnings multiples are stretched despite weak expected sales and earnings growth for the March quarter -- with 458 of 503 stocks in the index having reported. S&P 500 The index is\u2026","rel":"","context":"In "GDP and Activity"","block_context":{"text":"GDP and Activity","link":"https:\/\/thepatientinvestor.com\/index.php\/category\/economy\/gdp-and-activity\/"},"img":{"alt_text":"S&P 500","src":"https:\/\/i0.wp.com\/www.incrediblecharts.com\/images\/2024\/2024-05-14-spx.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.incrediblecharts.com\/images\/2024\/2024-05-14-spx.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.incrediblecharts.com\/images\/2024\/2024-05-14-spx.png?resize=525%2C300&ssl=1 1.5x"},"classes":[]},{"id":14207,"url":"https:\/\/thepatientinvestor.com\/index.php\/2016\/09\/20\/tpg-shares-drop-more-than-20-per-cent-on-disappointing-forecast\/","url_meta":{"origin":4203,"position":2},"title":"TPG shares drop more than 20 per cent on disappointing forecast","author":"ColinTwiggs","date":"September 20, 2016","format":false,"excerpt":"From Lucy Battersby: The market has fallen out of love with telco company TPG.... The cut-price telco beat guidance by just $300,000 when it has a history of beating guidance by tens of millions of dollars. It has also forecast earnings growth of 7 per cent this year, the lowest\u2026","rel":"","context":"In "Australia & NZ"","block_context":{"text":"Australia & NZ","link":"https:\/\/thepatientinvestor.com\/index.php\/category\/countries-regions\/australia-nz-countries-regions\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":13346,"url":"https:\/\/thepatientinvestor.com\/index.php\/2016\/05\/18\/wage-growth-hits-fresh-lows-abc-news\/","url_meta":{"origin":4203,"position":3},"title":"Wage growth hits fresh lows | ABC News","author":"ColinTwiggs","date":"May 18, 2016","format":false,"excerpt":"From Michael Janda: Wage growth has hit a fresh record low, with workers' pay rising just 0.4 per cent last quarter and 2.1 per cent over the past year. The latest seasonally adjusted Bureau of Statistics Wage Price Index is growing at the lowest level since the data began in\u2026","rel":"","context":"In "Australia & NZ"","block_context":{"text":"Australia & NZ","link":"https:\/\/thepatientinvestor.com\/index.php\/category\/countries-regions\/australia-nz-countries-regions\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":16299,"url":"https:\/\/thepatientinvestor.com\/index.php\/2018\/05\/23\/price-earnings-the-race-to-the-top\/","url_meta":{"origin":4203,"position":4},"title":"Price & Earnings: The Race to the Top","author":"Colin Twiggs","date":"May 23, 2018","format":false,"excerpt":"Now that 93% of S&P 500 stocks have reported first quarter earnings we can look at price-earnings valuation with a fair degree of confidence. My favorite is what I call PEMax, which compares Price to Maximum Annual Earnings for current and past years. This removes distortions caused by periods when\u2026","rel":"","context":"In "Earnings & Dividends"","block_context":{"text":"Earnings & Dividends","link":"https:\/\/thepatientinvestor.com\/index.php\/category\/investing\/earnings-dividends\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":16826,"url":"https:\/\/thepatientinvestor.com\/index.php\/2018\/08\/11\/sp-500-earnings-surge\/","url_meta":{"origin":4203,"position":5},"title":"S&P 500 earnings surge","author":"Colin Twiggs","date":"August 11, 2018","format":false,"excerpt":"Of companies in the S&P 500 index, 90.2% have reported their results for the quarter. According to S&P Dow Jones Indices: Sales growth at 11.0% year-on-year (Y\/Y) is close to a potential record. The earnings beat rate of 78% is also historically high, compared to an average of 67%. Operating\u2026","rel":"","context":"In "Stock Markets"","block_context":{"text":"Stock Markets","link":"https:\/\/thepatientinvestor.com\/index.php\/category\/stock-markets\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]}],"_links":{"self":[{"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/posts\/4203","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/comments?post=4203"}],"version-history":[{"count":0,"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/posts\/4203\/revisions"}],"wp:attachment":[{"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/media?parent=4203"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/categories?post=4203"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/tags?post=4203"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}